Don't get left behind! The modernized ClinicalTrials.gov is coming. Check it out now.
Say goodbye to ClinicalTrials.gov!
The new site is coming soon - go to the modernized ClinicalTrials.gov
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Restorative Neuromodulation for Lower Extremity Functions

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04171375
Recruitment Status : Completed
First Posted : November 20, 2019
Last Update Posted : January 6, 2022
Sponsor:
Collaborators:
University of California, Los Angeles
Hospital Authority, Hong Kong
Information provided by (Responsible Party):
Dr Monzurul Alam, The Hong Kong Polytechnic University

Brief Summary:
The overall objective of the proposed study is to restore lower-extremity functions of paraplegic individuals. Paralysis following Stroke or spinal cord injury (SCI) result harsh sufferings including lifelong dependence on wheelchairs and thus often life threatening conditions such as pressure sore resulted from the immobility. Recently, electrical stimulation targeting the lumbosacral spinal cord has shown activation of spinal circuits that control standing and walking functions; while body-weight supported locomotor training has shown overall health improvement of the paraplegic patients through activity dependent rehabilitation. In the current project we aim to combine the trans-spinal electrical stimulation and locomotor training in an efficient, cost-effective and simplified manner for functional rehabilitation. In this proposed study, Stroke and SCI paraplegics will be regularly trained to stand and walk on a body-weight support system with the aid of lower-limb orthoses and trans-spinal electrical stimulation. In progressive weeks the orthotic support of the lower-limb would be slowly lifted off and only the stimulation therapy will be delivered during the locomotor training. Repetitive training with this combination therapy, the spinal pathways would likely reorganize and would promote long-term rehabilitation of the lower-extremity. After successful demonstration of this in our laboratory settings, we aim to transform this technology for community use.

Condition or disease Intervention/treatment Phase
Spinal Cord Injuries Stroke Paralysis Device: trans-spinal Electrical Stimulation (tsES) Not Applicable

Detailed Description:

Spinal cord is composed of specialized neural networks, capable of executing different functions. Although the command for lower-limb functions such as standing and walking is primarily delivered from the brain, it was found that the spinal cord circuits not only execute it but also maintain the task and control the dynamics with proper feedback mechanisms with it's reflex circuitry. Simple bipedal standing and walking requires spatiotemporal coordination of muscles, limb joints, balance etc., their adaptation and control in gravity. For human, these physiological activities are well choreographed by sets of neural networks. In combination with afferent proprioceptive inputs, these network circuits work with the motor periphery to generate a series of motor acts during each task. Normally, the activity of these spinal networks are regulated supraspinally and by peripheral sensory inputs. In case of the loss of supraspinal inputs, resultant of a Stroke or spinal cord injury (SCI), motor tasks maybe enabled by directly activating these specialized spinal cord networks via external stimuli. Recent studies have demonstrated that neuromodulation via spinal cord stimulation can effectively restore lower-extremity functions in patients with chronic neurological injuries.

Traumatic injury to the central nervous system (CNS) such as SCI is devastating events leaving patients with impairment of motor, sensory and autonomic functions. Mainstay for the treatment is still limited to rehabilitation by physical therapy and training. In few patients, however, neuroplasticity and repair mechanisms are considered to contribute to recovery of paresis in the acute stage of the injury and stops in the chronic stage. But, recent groundbreaking studies have shown that the recovery can be further amplified in the chronic stage by the novel treatment of trans-spinal electrical stimulation. However, the rehabilitation related to this recovery is not very significant, and thus it is a challenge to be convinced with the efficacy of this new therapy. A combination therapy of trans-spinal electrical stimulation along with body-weight would promote better recovery and benefit the patients more. The current study will further assist the researchers to design such combinational therapeutic intervention for neurologically impaired patients to stimulate to walk again. Successful translation of this novel technology would facilitate the paraplegic community to become more healthy, independent and happy.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 2 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Trans-spinal Electrical Stimulation Along With Locomotor Training to Restore Walking in Paraplegic Patients
Actual Study Start Date : April 1, 2019
Actual Primary Completion Date : June 30, 2021
Actual Study Completion Date : November 30, 2021

Arm Intervention/treatment
Experimental: trans-spinal Electrical Stimulation (tsES) Device: trans-spinal Electrical Stimulation (tsES)
The trans-spinal pulsed-current stimulation utilizes non-invasive russian stimulation using a research grade stimulator and direct-current stimulation utilizes non-invasive constant stimulation using a medical grade stimulator. Both pulsed- and direct-current stimulation will be achieved with cutaneous cathode electrodes attached to the dorsal aspect of the back overlying at and bellow thoracic vertebrae and anode electrodes placed over the iliac crests or lower abdomen. Spinal motor evoked potentials will be induced by trans-spinal pulsed-current stimulation (parameters, 1 Hz with a 1 millisecond pulse width and monophasic waveform) to determine recruitment profiles of proximal and distal motor pools with increasing stimulation intensity ranging from 10-200 milliampere. Stimulation parameters for the therapeutic stimulation will be ranged from 5-50 Hz and 20-200 milliampere. For direct-current stimulation, the stimulation current will be kept constant at 2-2.5 milliampere.




Primary Outcome Measures :
  1. American Spinal Injury Association Impairment Scale [ Time Frame: 18 months ]
    An experienced physiotherapist will assess the patient at baseline and every month until the end of the study. The physiotherapist will use the American Spinal Injury Association Impairment Scale, a maximum possible score is 112 points to evaluate the sensation and muscle strengths of the patient. In particular, the examinations will involve manual muscle testing (with grades 0 to 5*; higher grades indicate stronger muscle strength), anorectal examination, as well as assessments of light touch (using a piece of cotton) and pinprick sensation (using a paper clip). All assessments will follow the myotome and dermatome. Based on the findings, an American Spinal Injury Association Impairment Scale grade will be given to indicate the severity of paralysis.

  2. Modified Ashworth Scale [ Time Frame: 18 months ]
    The spasticity of the patient was evaluated by the Modified Ashworth Scale, which is a 6-point scale to assess the resistance experienced by the therapist during passive muscle stretching. Higher scores indicate greater spasticity.

  3. Neuromuscular Recovery Scale [ Time Frame: 18 months ]
    The neuromuscular recovery scale will be used to quantify functionally motor tasks without compensation. It consists of 14 items/tasks (e.g., sit-to-stand, or standing). The physiotherapist will rate each item by comparing the deviations of patients' performance from the normative task performance in the movement pattern. Lower scores indicate major deviations. The maximum sum of all item scores is 161.

  4. Spinal Cord Independence Measure [ Time Frame: 18 months ]
    The functional performance of the patient will be assessed by the Spinal Cord Independence Measure. This is an observational examination contains three subscales with a maximum score of 100: (1) self-care; (2) respiration and sphincter; and (3) mobility. The self-care subscale includes six tasks (with a score ranging from 0 to 20). The respiration and sphincter subscale includes four tasks (with a score ranging from 0 to 40). The mobility subscale (with a score ranging from 0 to 40) contains two more subscales to evaluate mobility in "room and toilet", and "indoors and outdoors, on even surface". A higher score indicates a better function.


Secondary Outcome Measures :
  1. 5-10 meter overground walking test [ Time Frame: 12 months ]
    Tests overground walking improvements of the paraplegics.


Other Outcome Measures:
  1. Electrophysiology [ Time Frame: 18 months ]
    Muscular physiological activity will be collected via surface electromyography, mechanomyography and sonomyography of lower-limb muscles.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   19 Years to 55 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Be at least one year post-injury and not dependent on ventilation support
  • Lower-extremity paralyzed and half of key muscles below neurological level having a motor score of less than 2/5
  • Female subjects must be on standard contraception method and must not be pregnant throughout the study
  • Segmental reflexes are functional below the lesion
  • Ability to exercises 1-2 hours per day and commit for 1 year training program

Exclusion Criteria:

  • Cardiopulmonary disease or dysfunction, high blood pressure or other condition which contraindicate participation in lower extremity rehabilitation exercise
  • Received of Botox injections in the prior 6 months
  • Weakened bone, unhealed fracture, contracture, pressure sore, or infection that might interfere with the exercise
  • Thoracic or lumbar fusion with any metal which may interfere with electric currents
  • Other electronic implants such as cardiac pacemaker, defibrillator, shunt, stent etc.
  • Currently receiving treatments for pain management or spasticity or depression.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04171375


Locations
Layout table for location information
Hong Kong
Department of Biomedical Engineering, The Hong Kong Polytechnic University
Kowloon, Hong Kong
Sponsors and Collaborators
The Hong Kong Polytechnic University
University of California, Los Angeles
Hospital Authority, Hong Kong
Investigators
Layout table for investigator information
Principal Investigator: Monzurul Alam, PhD Research Assistant Professor
Layout table for additonal information
Responsible Party: Dr Monzurul Alam, Research Assistant Professor, The Hong Kong Polytechnic University
ClinicalTrials.gov Identifier: NCT04171375    
Other Study ID Numbers: HSEARS20190201002
First Posted: November 20, 2019    Key Record Dates
Last Update Posted: January 6, 2022
Last Verified: January 2022
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Spinal Cord Injuries
Paralysis
Spinal Cord Diseases
Central Nervous System Diseases
Nervous System Diseases
Trauma, Nervous System
Wounds and Injuries
Neurologic Manifestations